Clinical research has demonstrated substantial weight loss potential over extended treatment periods
Lilly said that some patients who dropped out of the trial left because they felt they were losing too much weight
Mounjaro's sales dip: How cheap generics are redrawing India's GLP-1 market The arrival of cheaper semaglutide alternatives signals that the Indian obesity drug market has moved from a launch-led boom into something more structurally competitive Eli Lilly's Mounjaro posted its first monthly sales drop in India in Marcha Rs 20-crore decline, from roughly Rs 135 crore in February to Rs 114 crorejust days after a clutch of Indian generics entered the country's booming GLP-1 market
These medications mimic the action of the glucagon-like peptide-1 hormone, stimulating insulin release, inhibiting glucagon secretion, and delaying gastric emptying, said Jeffrey Joseph, MD, an oculofacial plastic surgeon in private practice in Newport Beach, California
probiotics as well as prebiotics have been demonstrated to exert multiple beneficial effects in IBD (186) and T2D (187), including increased GLP-1 release (188)
After receiving approval from the U.S
